Participant flow

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer · Source last updated 2026-05-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Participants received cemiplimab plus platinum-based doublet chemotherapy

   id

   FG000

   title

   Part 1: Cemiplimab + Chemotherapy

2. description

   Participants received cemiplimab plus platinum-based doublet chemotherapy and ipilimumab

   id

   FG001

   title

   Part 1: Cemiplimab+AbbrevChemo+Ipilimumab

3. description

   Participants received platinum-based doublet chemotherapy

   id

   FG002

   title

   Part 1: Chemotherapy

4. description

   Participants received cemiplimab plus platinum-based doublet chemotherapy

   id

   FG003

   title

   Part 2: Cemiplimab + Chemotherapy

5. description

   Placebo matching cemiplimab plus platinum-based doublet chemotherapy

   id

   FG004

   title

   Part 2: Placebo + Chemotherapy

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         2

      4. group Id

         FG003

         num Subjects

         1

      5. group Id

         FG004

         num Subjects

         0

      type

      Adverse Event

   2. reasons

      1. group Id

         FG000

         num Subjects

         40

      2. group Id

         FG001

         num Subjects

         32

      3. group Id

         FG002

         num Subjects

         34

      4. group Id

         FG003

         num Subjects

         83

      5. group Id

         FG004

         num Subjects

         42

      type

      Death

   3. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         2

      4. group Id

         FG003

         num Subjects

         9

      5. group Id

         FG004

         num Subjects

         3

      type

      Lost to Follow-up

   4. reasons

      1. group Id

         FG000

         num Subjects

         9

      2. group Id

         FG001

         num Subjects

         4

      3. group Id

         FG002

         num Subjects

         9

      4. group Id

         FG003

         num Subjects

         25

      5. group Id

         FG004

         num Subjects

         21

      type

      Participant Decision

   5. reasons

      1. group Id

         FG000

         num Subjects

         4

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         5

      5. group Id

         FG004

         num Subjects

         0

      type

      Sponsor Decision

   6. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         1

      3. group Id

         FG002

         num Subjects

         2

      4. group Id

         FG003

         num Subjects

         4

      5. group Id

         FG004

         num Subjects

         1

      type

      Physician Decision

   7. reasons

      1. group Id

         FG000

         num Subjects

         34

      2. group Id

         FG001

         num Subjects

         49

      3. group Id

         FG002

         num Subjects

         36

      4. group Id

         FG003

         num Subjects

         132

      5. group Id

         FG004

         num Subjects

         76

      type

      Disease Progression

   8. reasons

      1. group Id

         FG000

         num Subjects

         9

      2. group Id

         FG001

         num Subjects

         7

      3. group Id

         FG002

         num Subjects

         10

      4. group Id

         FG003

         num Subjects

         14

      5. group Id

         FG004

         num Subjects

         7

      type

      Withdrawal of Consent

   9. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         5

      3. group Id

         FG002

         num Subjects

         2

      4. group Id

         FG003

         num Subjects

         7

      5. group Id

         FG004

         num Subjects

         0

      type

      Other than specified

   10. reasons

       1. group Id

          FG000

          num Subjects

          0

       2. group Id

          FG001

          num Subjects

          0

       3. group Id

          FG002

          num Subjects

          0

       4. group Id

          FG003

          num Subjects

          1

       5. group Id

          FG004

          num Subjects

          0

       type

       Non-compliance with Study Drug(s)

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         108

      2. group Id

         FG001

         num Subjects

         109

      3. group Id

         FG002

         num Subjects

         106

      4. group Id

         FG003

         num Subjects

         312

      5. group Id

         FG004

         num Subjects

         154

      comment

      Randomized

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         108

      2. group Id

         FG001

         num Subjects

         109

      3. group Id

         FG002

         num Subjects

         103

      4. group Id

         FG003

         num Subjects

         312

      5. group Id

         FG004

         num Subjects

         153

      type

      Randomized and Treated

   3. achievements

      1. group Id

         FG000

         num Subjects

         10

      2. group Id

         FG001

         num Subjects

         18

      3. group Id

         FG002

         num Subjects

         53

      4. group Id

         FG003

         num Subjects

         70

      5. group Id

         FG004

         num Subjects

         2

      type

      Completed Treatment

   4. achievements

      1. group Id

         FG000

         num Subjects

         10

      2. group Id

         FG001

         num Subjects

         9

      3. group Id

         FG002

         num Subjects

         9

      4. group Id

         FG003

         num Subjects

         31

      5. group Id

         FG004

         num Subjects

         4

      comment

      Completed Study

      type

      COMPLETED

   5. achievements

      1. group Id

         FG000

         num Subjects

         98

      2. group Id

         FG001

         num Subjects

         100

      3. group Id

         FG002

         num Subjects

         97

      4. group Id

         FG003

         num Subjects

         281

      5. group Id

         FG004

         num Subjects

         150

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice